Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination.

To determine possibly significant sites of AzAt labeling, the dataset was first screened for points that meet the criteria of a mutation rate fold change ≥1.5 and an average mutation count ≥100.

also in 649 other papers